BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1020 related articles for article (PubMed ID: 28577699)

  • 1. Budget Impact Analysis of Against Colorectal Cancer In Our Neighborhoods (ACCION): A Successful Community-Based Colorectal Cancer Screening Program for a Medically Underserved Minority Population.
    Kim B; Lairson DR; Chung TH; Kim J; Shokar NK
    Value Health; 2017 Jun; 20(6):809-818. PubMed ID: 28577699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand.
    Phisalprapa P; Supakankunti S; Chaiyakunapruk N
    J Med Econ; 2019 Dec; 22(12):1351-1361. PubMed ID: 31560247
    [No Abstract]   [Full Text] [Related]  

  • 3. Projecting total costs and health consequences of increasing mt-sDNA utilization for colorectal cancer screening from the payer and integrated delivery network perspectives.
    Hathway JM; Miller-Wilson LA; Jensen IS; Ozbay B; Regan C; Jena AB; Weinstein MC; Parks PD
    J Med Econ; 2020 Jun; 23(6):581-592. PubMed ID: 32063100
    [No Abstract]   [Full Text] [Related]  

  • 4. Against colorectal cancer in our neighborhoods (ACCION): A comprehensive community-wide colorectal cancer screening intervention for the uninsured in a predominantly Hispanic community.
    Shokar NK; Byrd T; Salaiz R; Flores S; Chaparro M; Calderon-Mora J; Reininger B; Dwivedi A
    Prev Med; 2016 Oct; 91():273-280. PubMed ID: 27575314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial.
    Gupta S; Halm EA; Rockey DC; Hammons M; Koch M; Carter E; Valdez L; Tong L; Ahn C; Kashner M; Argenbright K; Tiro J; Geng Z; Pruitt S; Skinner CS
    JAMA Intern Med; 2013 Oct; 173(18):1725-32. PubMed ID: 23921906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of new non-invasive tests for colorectal cancer screening: the relevance of information on adenoma detection.
    Haug U; Knudsen AB; Lansdorp-Vogelaar I; Kuntz KM
    Int J Cancer; 2015 Jun; 136(12):2864-74. PubMed ID: 25403937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical case management and navigation for colonoscopy screening in an academic medical center.
    Cavanagh MF; Lane DS; Messina CR; Anderson JC
    Cancer; 2013 Aug; 119 Suppl 15():2894-904. PubMed ID: 23868484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for Colorectal Cancer With Fecal Immunochemical Testing With and Without Postpolypectomy Surveillance Colonoscopy: A Cost-Effectiveness Analysis.
    Greuter MJE; de Klerk CM; Meijer GA; Dekker E; Coupé VMH
    Ann Intern Med; 2017 Oct; 167(8):544-554. PubMed ID: 28973514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of efficacy and cost-effectiveness when screening colonoscopy is performed by nongastroenterologists.
    Hassan C; Rex DK; Zullo A; Cooper GS
    Cancer; 2012 Sep; 118(18):4404-11. PubMed ID: 22707430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal use of colonoscopy and fecal immunochemical test for population-based colorectal cancer screening: a cost-effectiveness analysis using Japanese data.
    Sekiguchi M; Igarashi A; Matsuda T; Matsumoto M; Sakamoto T; Nakajima T; Kakugawa Y; Yamamoto S; Saito H; Saito Y
    Jpn J Clin Oncol; 2016 Feb; 46(2):116-25. PubMed ID: 26685321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrasting Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening Under Commercial Insurance vs. Medicare.
    Ladabaum U; Mannalithara A; Brill JV; Levin Z; Bundorf KM
    Am J Gastroenterol; 2018 Dec; 113(12):1836-1847. PubMed ID: 29904156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of colorectal cancer screening using colonoscopy, fecal immunochemical test, and risk score.
    Sekiguchi M; Igarashi A; Sakamoto T; Saito Y; Esaki M; Matsuda T
    J Gastroenterol Hepatol; 2020 Sep; 35(9):1555-1561. PubMed ID: 32167186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Against Colorectal Cancer in Our Neighborhoods, a Community-Based Colorectal Cancer Screening Program Targeting Low-Income Hispanics: Program Development and Costs.
    Shokar NK; Byrd T; Lairson DR; Salaiz R; Kim J; Calderon-Mora J; Nguyen N; Ortiz M
    Health Promot Pract; 2015 Sep; 16(5):656-66. PubMed ID: 25983085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal neoplasia prevalence in a predominantly Hispanic community: Results from a colorectal cancer screening program in Texas.
    Willauer AN; Zuckerman MJ; Alomari A; Alvarado LA; Salaiz R; Casner N; Dwivedi AK; Shokar NK
    Am J Med Sci; 2022 Oct; 364(4):394-403. PubMed ID: 35398033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Effectiveness and Cost Effectiveness of a Multitarget Stool DNA Test to Screen for Colorectal Neoplasia.
    Ladabaum U; Mannalithara A
    Gastroenterology; 2016 Sep; 151(3):427-439.e6. PubMed ID: 27311556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colon cancer screening for Colorado's underserved: a community clinic/academic partnership.
    Wolf HJ; Dwyer A; Ahnen DJ; Pray SL; Rein SM; Morwood KD; Lowery JT; Masias A; Collins NJ; Brown CE; DeMaio Goheen CA; McAbee KE; Sauaia A; Byers TE
    Am J Prev Med; 2015 Mar; 48(3):264-70. PubMed ID: 25547926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness and budget impact analysis of a population-based screening program for colorectal cancer.
    Pil L; Fobelets M; Putman K; Trybou J; Annemans L
    Eur J Intern Med; 2016 Jul; 32():72-8. PubMed ID: 27157827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-Effectiveness of Community Interventions for Colorectal Cancer Screening: Low-Income Hispanic Population.
    Lairson DR; Kim J; Byrd T; Salaiz R; Shokar NK
    Health Promot Pract; 2018 Nov; 19(6):863-872. PubMed ID: 29290126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of colorectal cancer screening in high-risk Spanish patients: use of a validated model to inform public policy.
    Ladabaum U; Ferrandez A; Lanas A
    Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2765-76. PubMed ID: 20810603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.